Publication details

Predictors of premature withdrawal and dose reduction in patients with chronic hepatitis C treated with Peginterferon alfa-2a (40kD) plus ribavirin in a large, multinational, open-label expanded access program.

Title in English Predikce předčasného vysazení a redukce dávky PEG-IFN alfa-2a a ribavirinu u nemocných s chronickou hepatitidou C.
Authors

LEE Samuel ROBERTS Stuart BERAK Hanna DUSHEIKO Geoffrey HARLEY Hugh GANE Edward HUSA Petr

Year of publication 2009
Type Article in Periodical
Magazine / Source Hepatology
MU Faculty or unit

Faculty of Medicine

Citation
Field Epidemiology, infectious diseases and clinical immunology

You are running an old browser version. We recommend updating your browser to its latest version.

More info